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Radiation therapy is an established modality in the treatment of head and neck cancer patients. Compromised
wound healing in irradiated tissues is a common and challenging clinical problem. The pathophysiology and
underlying cellular mechanisms including the complex interaction of cytokines and growth factors are still not
understood completely. In this review, the current state of research regarding the pathomechanisms of
compromised wound healing in irradiated tissues is presented. Current and possible future treatment strategies are
critically reviewed.
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Radiation is employed as neoadjuvant, primary and adju-
vant therapy for head and neck cancer. Complications
after radiation therapy occur in up to 60 percent of sur-
gical patients. Clinical sequelae include skin atrophy, soft
tissue fibrosis, desquamation, epithelial ulceration, fistula
formation and major vessel rupture [1,2]. Impaired peri-
and postoperative wound healing and the complications
associated with it can be observed [3,4] frequently and
may require extensive reconstructive efforts [5-7]
(Figure 1).Physiological wound healing
Adequate wound healing involves interactions of cells.
Cell biologic mechanisms relevant to the process include
interaction of keratinocytes, fibroblasts and endothelial
cells [8]. Epithelial closure of a wound is an important
aspect of this complex biological process and relies pri-
marily on the concerted action of activated keratinocytes
and dermal fibroblasts [9]. Three phases of wound heal-
ing with distinctive biochemical profiles have been
described (Figure 2).
Hemostasis and inflammation (phase 1, day 0 to 4),
are followed by proliferation (phase 2, day 3 to week 3)
and maturation (phase 3, week 3 to 2 years) [10,11].* Correspondence: frank.haubner@klinik.uni-regensburg.de
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of interacting cytokines, growth factors and their cellular
receptors.Effects of radiation therapy on wound healing
Wound healing occurs in an ordered sequence of cel-
lular interactions. Repetitive radiation injury disrupts
this highly organized sequence of events, resulting in
repetitive inflammatory responses and ongoing cellular
regeneration [12].
There is an important distinction to be made between
the early and the late side-effects of radiation therapy:
Early side effects include erythema, dry desquamation,
hyperpigmentation and hair loss [13]. Late effects in-
clude skin atrophy, dryness, telangiectasia, dyschromia,
dyspigmentation, fibrosis, and ulcers [14].
The inflammatory and proliferative phases may be dis-
rupted by the early effects of radiation. Affected factors
during the inflammatory phase include transforming
growth factor beta (TGFβ), vascular endothelial growth
factor (VEGF), tumor necrosis factor-α (TNF-α),
interferon-γ (IFN- γ) and proinflammatory cytokines
such as interleukin-1 and interleukin-8 [12]. These cyto-
kines are overexpressed after the radiation injury leading
to uncontrolled matrix accumulation and fibrosis [15].
The proliferative phase is characterized by granulation
tissue formation, re-epitheliaziation and neovasculariza-
tion. This phase is mainly regulated by TGFβ, VEGF, epi-
dermal growth factor (EGF), fibroblast growth factoral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Clinical case of a 55-year-old male, six months after
primary radiochemotherapy due to an advanced squamous cell
carcinoma of the hypopharynx. Skin atrophy and soft tissue
necrosis were observed 8 weeks after the completion of therapy.
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Nitric oxide (NO) promotes wound healing by an induc-
tion of collagen deposition [16]. NO levels have been
reduced in irradiated wounds of experimental animals
[17]. This finding may explain the impaired strength of
irradiated wounds.
During the remodeling phase, matrix metalloprotei-
nases (MMP) and their tissue inhibitors are central to
the process [18,19]. MMP-1 is decreased after radiation
therapy, which may contribute to inadequate soft tissue
reconstitution [19] (Table 1).
Keratinocytes represent a crucial cell type in the repair
of late epithelial wounds and ulcers. Multiple molecular
biological changes are observed in this cell after radi-
ation when compared to radiation-naïve skin. In human
radiogenic wounds, these cells show a shift in the ex-
pression from high molecular keratins 1 and 10 to theFigure 2 Schematic concept of wound healing. Adapted from Hunt Tlow molecular keratins 5 and 14. In non-healing ulcers,
keratinocytes display a decreased expression of trans-
forming growth factor-alpha and –beta(1), fibroblast
growth factor 1 and 2, keratinocyte growth factor, vascu-
lar endothelial growth factor, and hepatocyte growth fac-
tor. Expression of the matrix metalloproteinases 2, 12
and 13 has been shown to be elevated in irradiated
human keratinocytes and fibroblasts [20].
Fibroblasts play the central role in wound healing
through deposition and remodeling of collagen fibers. In
irradiated tissue, fibroblasts have been shown to generate
a disorganized deposition of collagen bundles. One likely
mechanism resulting in disorganized collagen deposition
is dysregulation of MMP and TIMP. These enzymes
regulate extracellular matrix synthesis [21,22]. As TGF-
beta in turn regulates MMPs and TIMPs, this cytokine
may be of particular relevance to radiogenic ulcers.
Current strategies in treating irradiated wounds
Established strategies in treating radiogenic ulcers with
delayed and inadequate healing include standard wound
care, vacuum-assisted devices, substitution of nutritional
deficiencies, and measures to optimize blood and oxygen
supply [6,23].
Hyperbaric oxygen seems to optimize the partial pres-
sure of tissue oxygen. It is frequently used for the treat-
ment of osteoradionecrosis [24-27]. The postulated
effects include an increased capillary density and more
complete neovascularization [28-33]. Kendall et al. tested
hyperbaric oxygen in a cell culture model and found that
its application resulted in the downregulation of 9 genes
involved in adhesion, angiogenesis, inflammation and
oxidative stress [34]. Interleukin-8 mRNA levels were
also suppressed after daily exposure of hyperbaric oxy-
gen to endothelial cells in this study [34]. IL-8 is one keyK [8].
Table 1 Possible key factors affected by radiotherapy
with respect to the phases of wound
Phase of wound
healing
Factors affected by radiation therapy
Inflammation TGFβ, VEGF, interleukin-1, interleukin-8, TNFα, IFN-γ
Proliferation TGFβ, VEGF, EGF, FGF, PDGF, NO
Remodelling MMP-1, MMP-2, MMP-12, MMP-13, TIMP
Wound healing factors affected by radiation therapy.
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suggests that the benefit of hyperbaric oxygen may not
be limited to osteoradionecrosis and further investiga-
tions regarding additional therapeutic effects may be
valuable.
Currently, hyperbaric oxygen therapy is clinically used
in chronic diabetic ulcers and wound healing complica-
tions after radiotherapy. Its efficacy has been proven by
several randomized trials, but it is it is important to
emphasize that for both diabetic wounds and radiation
injuries, this therapy is used in conjunction with stand-
ard wound care management techniques [35]. A possible
new approach for the hyperbaric oxygen therapy is the
treatment of dermal wounds after flap surgery. Multiple
case reports and animal studies have been written on
this issue. Prospective clinical trials are necessary to sup-
port the application of hyperbaric oxygen to improve
flap survival [36].Future aspects in the treatment of irradiated
wounds
Research into new therapeutic approaches to treat radio-
genic ulcers includes: Special dressings, injection of
(multipotent) cells, topical administration of active sub-
stances and the use of growth factors (Table 2).Special dressings
Different types of membranes and other covers of radio-
genic skin injuries have been developed in the past.Table 2 Current experimental strategies in the treatment of i
Experimental
Dressings Injection of cells Topicals
hydrogel membranes unirradiated fibroblasts polyphenolic biof
bacterial cellulose dermis-derived multipotent cells phenylbutyrate, va
silver nanoparticles adipose-derived stem cells tissue and microb
skin allografts copper tripeptide
Thrombin recepto
Overview on current experimental strategies.Hydrogel membranes
Hydrogel membranes have a stable, flexible and trans-
parent structure. Data of Lu et al. indicate that the
hydrogel membranes act as a semiocclusive dressing and
maintain a moist environment over the wound bed.
Through this mechanism, re-epithelialization is thought
to be enhanced because of the accumulation of cytokines
and growth factors that support wound healing [37].
The use of hydrogels for partial thickness wounds after
burns or laser resurfacing is supported by case reports
[38]. Prospective, controlled data on their treatment
effect in radiogenic wounds are not available.
Silver membranes
Bacterial cellulose impregnated membranes and poviar-
gol, an antiseptic substance containing silver, was shown
to accelerate the healing of irradiated wounds in an ani-
mal model [39]. A recent animal study has revealed that
silver nanoparticles have the potential to promote
wound healing through accelerated re-epithelialization
and enhanced differentiation of fibroblasts. The exact ef-
fect of silver-coated membranes on skin repair is only
partially understood. Hypothetic mechanisms include
the fact that collagen bundle organization and the tensile
properties of the skin [40] are found to be improved.
Skin allografts
A human deceased-donor skin allograft provides dermo-
protection and promotion of re-epithelialization. It is
utilized until autografting is possible or re-harvesting of
donor sites becomes available [41]. This treatment is
currently limited to burn injuries. It may be hypothe-
sized that similar effects may be achieved in radiogenic
ulcers, but clinical data and trials with sufficient num-
bers are not available.
Injection of cells
Wound healing is a complex mechanism that requires
active cellular interactions. These interactions are onlyrradiated wounds
strategies
Application of growth factors
lavonoids TGF-beta (1,2,3) and antisense TGF-beta
oligonucleotides
lproic acid, ascorbic acid platelet-derived growth factor
ial transglutaminases recombinant human epidermal growth factor
macrophage colony stimulating factor
r-activating peptide granulocyte colony stimulating factor
basic fibroblast growth factor
vascular endothelial growth factor
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are present. Radiation leads to impaired cellular activity
and cell death. Injection of cells has the potential of en-
hancing wound healing in irradiated tissues. Neverthe-
less, there is a significant risk of infection and possible
tumor induction by injecting viable cells in vivo. All of
the studies discussed below have to be seen in this con-
text. All interventions are experimental and presently
not applied in routine clinical practice.
Autologous fibroblasts
Autologous, unirradiated fibroblasts were shown in a rat
model by Ferguson et al. to significantly improve healing
of the irradiated surgical wound. This was evidenced by
injections of culture medium, irradiated fibroblasts and
non-irradiated fibroblasts in previously irradiated surgi-
cal wounds. The autologous non-irradiated fibroblasts
caused greater increases of breaking load and ultimate
tensile strength of the wounds than the irradiated control
cells [42]. Other authors also report that implanting iso-
lated dermal fibroblasts leads to a significant increase of
wound strength in irradiated mice skin. This effect may
rescue wounds from the otherwise irreversible effect of
prior irradiation [43]. Both studies show promise for the
treatment of irradiated wounds in patients. The injection
of autologous fibroblasts would be possible at the end of
a surgical procedure in irradiated patients. But this
method has not yet led to the conduction of human clin-
ical trials. One problem in this context is the risk of indu-
cing neoplastic lesions by injecting viable cells.
Multipotent stem cells
Dermis-derived multipotent stem cells seem to be easily
harvested from animal skin.
Chunmeng reports that both topical and systemic
transplantation of dermis-derived multipotent cells
accelerates healing after a radiation-induced injury [44].
The suggested mechanism is the synthesis of important
wound healing factors such as VEGF, PDGF and TGF-
beta by these cells. An interesting finding of this animal
study on rats was also the analysis of the cell superna-
tants. A medium previously incubated with dermis-
derived stem cells seems to contain relevant amounts of
wound-healing promoting factors such as VEGF, PDGF
and TGF-beta. This presents a valuable approach for fur-
ther clinical studies.
Human mesenchymal stem cells have also been dis-
cussed in the therapy of radiogenic ulcers. Adipose-
derived stem cells have been described for the therapy of
limited local injuries and seem to improve angiogenesis
and the reconstitution of dermal architecture [45].
Akita et al. describe the use of adipose-derived stem
cells (ADSC) in a female suffering from a radiogenic
wound 40 years after irradiation due to a uterinecarcinoma. They used an artificial dermis impregnated
with ADSC to cover the wound bed and injected ADSC
into the margins. This method was combined with the
local administration of a basic fibroblast growth factor to
improve angiogenesis. The authors documented excellent
results of wound healing and a durable regenerated tissue
after 1.5 years [46]. The results of this study may be open
to various interpretations. The observed effect may be
due to the adipose-derived stem cells, the artificial der-
mis or the application of growth factors. Combined or
additive effects cannot be excluded to explain the success
of this approach. Clinical studies investigating the effect
of adipose-derived stem cell injections into radiogenic
wounds are not available. Hadad et al. developed a
wound-healing model to study such effects in pigs [47].
They found no effect of the ASCs injections alone, but
they could document improved wound healing by a com-
bination therapy of ASC and platelet rich plasma injec-
tions into irradiated wounds. The most important effects
were an accelerated wound closure and an increased
microvessel density after the combined treatment.
A proangiogenetic effect of stem cell injections has
been suggested by the authors, but other mechanisms
may also serve to explain the findings in this study. New
vessel formation and the optimizing of tissue microcir-
culation present a valuable effect of stem cell injections
with respect to cutaneous wound healing. But the bene-
fit on wound healing might end up providing a favorable
environment for tumor recurrence after radiotherapy.
High risk constellations or the application of stem cell
injections in elderly people who have a diminished life
time may put these patients at risk for developing tumor
recurrence, which would justify further clinical trials.
The clinical observations of Akita et al. are supported by
another porcine study. Porcine skin seems to react simi-
larly to human skin as far as radiogenic injuries are con-
cerned. Also wound-healing mechanisms are similar in
humans and pigs [48]. That is why porcine animal stud-
ies are of major value in this field of research. Forcheron
et al. injected autologous adipose-derived stem cells into
the skin of pigs irradiated with 50Gy [49]. This study fo-
cused on the cutaneous radiation syndrome. In this con-
text the authors observed an improved clinical wound
healing and an enhanced re-epitheliasation in animals
injected with adipose-derived stem cells.
The antioxidant effects of adipose-derived stem cells
[50] are reported by Kim et al.. These effects seem to be
mainly mediated through the activation of dermal fibro-
blasts and keratinocytes via the paracrine mechanism.
Another advantage of adipose-derived stem cells over
other stem cell sources is that they are easily obtained in
large quantities by liposuction. Also their potency to
synthesize growth factors and cytokines shows promise
for the use in skin repair and regeneration [51,52]. A cell
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of adipose-derived stem cells on cutaneous wound healing
[53]. In their study, the proliferation of fibroblasts and
their collagen synthesis were increased by a conditioned
medium of adipose-derived stem cells in vitro.
The studies mentioned above reveal that adipose-
derived stem cells seem to interact directly and via para-
crine mechanisms with the key cells of wound healing.
Clinical trials analyzing the role of these cells and their
combination with other wound-healing promoting fac-
tors would contribute to a better understanding of the
potential value of this treatment regimen.
Experimental application of active agents
The topical application of active agents to reduce the
side effects of radiation therapy was analyzed in several
cell culture and animal studies.
Bioflavonoids
Biologically active polyphenolic bioflavonoids have been
shown in cell culture studies with keratinocytes to have
positive effects on angiogenesis. The suggested mechan-
ism is an increased expression of the vascular endothelial
growth factor via the TNF (tumor necrosis factor)-alpha-
pathway [54]. Angiogenesis plays a central role in wound
healing. VEGF is believed to be the most prevalent, effica-
cious and long-term signal that is known to stimulate
angiogenesis in wounds.
Histone deacetylase inhibitors
Histone deacetylase inhibitors (phenylbutyrate, trichosta-
tin A and valproic acid) were shown to suppress the cu-
taneous radiation syndrome in rat skin. Chung et al.
analyzed different histone deacetylase inhibitors with re-
spect to acute skin reaction and dermal fibrosis. They
used vaseline as a negative control and performed immu-
nohistological analyses. The underlying mechanism seems
to be the suppression of the aberrant expression of
radiation-induced transforming growth factor-beta 1 and
2 and tumor necrosis factor alpha [55].
This study presents the value of antitumor histone
deacetylase inhibitors which may suppress cutaneous ra-
diation syndrome and are possible new agents for in-
creasing therapeutic gain in cancer radiotherapy.
Ascorbic acid
Ascorbic acid has been shown to result in the significant
acceleration of healing of radiogenic ulcers. This was
shown in a mouse model with doses of 10,16 and 20 Gy.
A full thickness skin wound was created after radiation.
Histological evaluations were performed at various times
after wounding. Pretreatment with ascorbic acid aug-
mented the synthesis of collagen significantly as revealed
by an increase in hydroxyproline content. In the ascorbicacid group, an earlier wound closure was observed com-
pared to the control group [56]. Optimizing collagen
synthesis in a poorly healing wound by the application
of ascorbic acid seems to be reasonable, but clinical
trials are still lacking.
Copper tripeptide
Copper tripeptide accelerates the growth of normal and
irradiated fibroblasts, which was shown in a cell culture
study by Pollard et al.:
Primary human dermal fibroblasts were explanted
from intraoperative specimens obtained from patients
after radiation therapy for head and neck cancer. Normal
unirradiated fibroblasts served as a control. Irradiated
fibroblasts treated with copper tripeptide showed a simi-
lar proliferation rate as the untreated controls, and pro-
duced significantly more basic fibroblast growth factor
and vascular endothelial growth factor than untreated
controls. An early increase in growth factors and cell
proliferation by irradiated fibroblasts treated with copper
tripeptide may improve wound healing [57].
Thrombin receptor-activating peptide
Thrombin receptor-activating peptide (P517-30) has
been shown to increase wound-breaking strength in irra-
diated tissues. This substance is a synthesized high-
affinity thrombin receptor binding peptide. In a rat
model, Cromack et al. revealed that P517-30 directly sti-
mulates resident endothelial cells and fibroblasts to over-
come dermal and circulating monocytic deficits. These
results suggest a mechanism to accelerate wound healing
with a potential clinical application and emphasize the
activity of thrombin as a growth factor [58]. Special
hydrogels could be possible applications for these
growth factors [59].
Application of growth factors
Different growth factors have been analyzed for their po-
tential role in wound healing, albeit their carcinogenic
potential must be taken into consideration.
Important factors that may be suitable for this therapy in-
clude recombinant human granulocyte colony-stimulating
factor (rhG-CSF), recombinant human macrophage colony-
stimulating factor (rhM-CSF), basic fibroblast growth factor,
TGF-beta and an inhibitor of transforming growth factor
(TGF)-beta(1) receptor kinase [60-65].
TGF-beta and TGF-beta antisense oligonucleotides
The exogenous application of TGF-beta (1) and (3) has
the potential to act as a radioprotective agent, especially
in adjuvant therapeutic regimens. In a rat model,
reduced TGF-beta(3) expression was observed in the
irradiated graft bed and induction of collagen synthesis
was observed after application of TGF-beta (1) [66,67].
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ting after radiation therapy remains to be seen, because
TGF-beta suppression seems to have favorable effects as
well:
TGF-β is a strong stimulator of extracellular matrix
deposition. A new pharmacological approach was the
development of the TGF-beta antisense oligonucleotide
technology. This intervention shows promise as a
therapeutic option for the inhibition of proteolytic tis-
sue destruction, which is one key approach to optimize
wound healing. Irradiated wounds often fail to heal be-
cause of high amounts of MMPs. TGF-beta antisense
oligonucleotides seem to affect the major cell types of
dermal wound healing: Fibroblasts, keratinocytes and
endothelial cells were influenced in their gene expres-
sion of MMPs. MMP-1 and MMP-9 were significantly
decreased after the treatment of fibroblasts and keratino-
cytes with TGF-beta antisense oligonucleotides in vitro
[68]. Animal models of wound healing and scarring after
eye surgery documented an anti-scarring effect of the
TGF-beta antisense oligonucleotides in vivo [69].
TGF-beta antisense oligonucleotide technology shows
promise. VEGF up-regulation was observed in vitro
and a pro-angiogenetic effect of TGF-beta antisense
oligonucleotides in radiation-induced dermal wounds
was suggested [70]. Another study showed TGF-beta
antisense oligonucleotides result in an increased ex-
pression of MMP protein and mRNA in tissue samples
from radiation-induced chronic dermal wounds when
compared to normal human skin. These effects were
observed by immunohistochemistry and microarray
analysis. Antisense TGF-beta oligonucleotide treatment
also significantly down-regulates MMP secretion
in vitro. Through these mechanisms, proteolytic tissue
destruction may be inhibited in radiogenic ulcers [71].
Clinical trials would be helpful to better understand
the effects of TGF-beta oligonucleotides in vivo. The
interesting issue in this context is balancing the posi-
tive effects of matrix formation by TGF-beta and the
negative side effects of a TGF-beta overexpression after
radiotherapy.
Platelet-derived growth factor
Platelet-derived growth factor (PDGF) may be useful as
a topical agent in post-irradiation surgical incisions
[47,72]. PDFG is already in clinical use and shows favor-
able results. In previously irradiated tissue, rhPDGF (re-
combinant human platelet-derived growth factor) has
been shown to enhance wound healing through the induc-
tion of granulation tissue formation. PDGF is a cytokine
that is only activated in the presence of bone marrow-
derived cells like wound macrophages. The transformation
of wounds from a chronic to a short-term healing state
after rhPDGF treatment was documented by serialhistological examinations. The risk of tumor induction is
difficult to quantify and must be considered prior to clin-
ical application [73,74].
Granulocyte macrophage-colony stimulating factor
Granulocyte macrophage-colony stimulating factor
(GM-CSF) has been shown to modulate lipid peroxida-
tion and glutathione content in skin wounds [75].
It has been demonstrated that GM-CSF increases the
number of neutrophils, eosinophils and monocytes with
corresponding bone marrow changes and might be suit-
able for different approaches in cancer therapy [76]. Irradi-
ation decreases incisional healing and produces oxygen
radicals that damage cells. Because of the lipid component
in the membrane, the cellular membranes are particularly
susceptible to radiation damage due to peroxidation.
Glutathione acts as a co-substrate in the enzymatic repair
of radiation damage. Suppressed levels of glutathione have
been shown to increase after the administration of gran-
ulocyte macrophage-colony stimulating factor in irra-
diated rats. The reduction of complications associated
with radiochemotherapy is one possible goal of GM-CSF
application.
Recombinant human epidermal growth factor (rhEGF)
The use of recombinant human epidermal growth factor
(rhEGF) was studied in mice after radiation with 45 Gy.
Histological examinations showed that treatment with
EGF accelerated normal wound healing when compared
to no treatment. Collagen distribution was significantly
increased in the group treated with EGF. Dermal and
epidermal structure was also more stable in the treat-
ment group [77].
Combined treatments
Pollard et al. investigated cytokine expression in a cell
culture model of irradiated human skin isolates. Basic
fibroblast growth factor and vascular endothelial growth
factor were found to be less expressed in the radiation-
induced dermal wounds [78]. These authors concluded
that an early combined increase in basic fibroblast
growth factor and vascular endothelial growth factor
production in irradiated fibroblasts may improve wound
healing [57]. Follow-up clinical studies have not yet been
conducted.
There is some evidence to support the combination
of different growth factors to escalate their therapeutic
effect [79]. Important factors that may be suitable for
combination therapy include recombinant human gran-
ulocyte colony-stimulating factor (rhG-CSF), recombin-
ant human macrophage colony-stimulating factor
(rhM-CSF), basic fibroblast growth factor and an in-
hibitor of transforming growth factor (TGF)-beta(1) re-
ceptor kinase [60-65].
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after local irradiation with 30 Gy. Recombinant human
granulocyte colony-stimulating factor (rhG-CSF), recom-
binant human macrophage colony-stimulating factor
(rhM-CSF) and an inhibitor of transforming growth fac-
tor (TGF)-beta1 receptor kinase, were injected into a
full-thickness incisional wound site in the dorsal skin.
Following combined treatment with the above three
compounds the breaking strength of the irradiated skin
increased to approximately one-half of that in the non-
irradiated skin. Histological analysis of the wounded skin
revealed an increase in the formation of collagen fibers.
Moreover, the increased breaking strength was associated
with an increase in a subpopulation of fibrocytes [60].
Conclusion
Radiotherapy is an integral modality of head and neck
cancer therapy. Compromised wound healing is an im-
portant side effect of radiation therapy. The current
body of literature comprises a large number of studies
investigating the molecular, cellular and clinical effects
of compromised wound healing as well as current and
possible future therapeutic strategies. Many of the
mechanisms leading to cell injuries are still not com-
pletely understood. A better understanding of tolerance
doses, improved timing of the radiation regimen, and ra-
diation sources would allow a more focused tumor treat-
ment. These advances have led to an improved, but not
yet complete protection of healthy tissues. The clinical
challenge to optimize wound healing in irradiated
patients remains. The present paper critically reviews
and summarizes the literature concerning the biology
and possibly therapeutic strategies of radiation-induced
compromise in wound healing, including stem cell injec-
tions and application of growth factors.
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